サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1477108

ニューロモデュレーション市場：技術別、用途別、生体材料別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測

Neuromodulation Market, By Technology, By Application, By Biomaterial, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 293 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
ニューロモデュレーション市場：技術別、用途別、生体材料別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測
出版日: 2024年04月25日
発行: AnalystView Market Insights
ページ情報: 英文 293 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ニューロモデュレーション市場規模は2023年に59億8,700万米ドルとなり、2024年から2032年にかけてCAGR 11.5％で拡大

ニューロモデュレーション市場- 市場力学

神経疾患の有病率の増加が市場需要を促進

神経疾患が一般的になるにつれて、ニューロモデュレーション市場は拡大しています。年齢を重ねるにつれて、私たちの身体は感染症を撃退したり自己修復したりする能力を失い始め、糖尿病、パーキンソン病、整形外科的障害、アルツハイマー病、胃腸障害など、多くの慢性疾患にかかりやすくなります。世界の高齢者人口の増加により、神経疾患を患う人が増えています。とはいえ、ギリシャ、韓国、スペイン、ポルトガル、日本、スペインなどの国々では高齢者人口の割合がはるかに高く、2050年までにこれらの国々の人口の40％が65歳以上になると予測されています。65歳以上の人口は、2050年までに世界全体でほぼ3倍になると予想されています。したがって、ニューロモデュレーション装置の普及は、神経疾患の有病率の高さを特徴とする高齢化人口の顕著な増加によって推進されると予測されます。このことは、予測期間を通じて世界のニューロモデュレーション市場の拡大に寄与すると思われます。

ニューロモデュレーション市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約11.5%のCAGRで毎年成長すると予測されています。

技術別では、予測期間中、体内ニューロモデュレーションが最も高いCAGRで成長すると予測されています。

用途別では、パーキンソン病分野が予測期間中に市場をリードすると予測されます。

地域別では、北米が2023年の売上高をリードしました。

ニューロモデュレーション市場-セグメンテーション分析：

世界のニューロモデュレーション市場は、技術、用途、生体材料、地域に基づいて区分されます。

技術に基づいて、市場は内部ニューロモデュレーションと外部ニューロモデュレーションに分類されます。予測期間中、内部ニューロモデュレーション分野が最も高いCAGRで成長すると予想されます。慢性神経疾患や疼痛疾患の患者は、標的を絞って調節可能な刺激を与える内部ニューロモデュレーション療法を使用することで、症状が大幅に緩和される可能性があります。これらの治療法の有効性と応用は、さらなる技術的進歩によって改善されると予想され、内部ニューロモデュレーション分野のさらなる市場拡大を後押しします。

用途別に見ると、片頭痛、慢性疼痛、腰痛症、尿失禁・便失禁、パーキンソン病、てんかん、振戦、うつ病、その他に分類されます。パーキンソン病分野は、高齢化人口の増加により、予測期間中市場をリードすると予想されます。

ニューロモデュレーション市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。予測期間中、北米が市場を独占すると予想されます。大規模な製薬・バイオ医薬品産業と、定評のある市場企業の存在、最先端技術導入のための米国での投資拡大が、同国での市場拡大を牽引すると予想されます。例えば、2022年にパーキンソン財団が発表した最新データによると、米国におけるパーキンソン病（PD）の年間診断件数は約9万件になると予測されており、これは従来の予測である6万件から50%増加します。

ニューロモデュレーション市場-競合情勢：

市場に参入している主要企業は、Bioventus Inc.、Medtronic、Nevro Corporation、Neuronetics、MicroTransponder、NeuroPace Inc.、Boston Scientific Corporation、MicroTransponder、LivaNova PLC、Abbott、NeuroSigmaなどです。これらの企業は、製品発売、買収、事業拡大など、最大市場シェアを獲得するためにいくつかの戦略を採用しています。

目次

第1章 ニューロモデュレーション市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ニューロモデュレーションの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ニューロモデュレーション産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 ニューロモデュレーション市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 ニューロモデュレーション市場情勢

  • ニューロモデュレーション市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ニューロモデュレーション市場- 技術別

  • 概要
    • 技術別セグメントシェア分析
    • 内部ニューロモデュレーション
    • 外部ニューロモデュレーション

第8章 ニューロモデュレーション市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 片頭痛
    • 慢性の痛み
    • フェイルバック症候群
    • 尿失禁および便失禁
    • パーキンソン病
    • てんかん
    • 振戦
    • うつ
    • その他

第9章 ニューロモデュレーション市場- バイオマテリアル別

  • 概要
    • バイオマテリアル別セグメントシェア分析
    • 高分子生体材料
    • 金属バイオマテリアル
    • セラミックバイオマテリアル

第10章 ニューロモデュレーション市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- ニューロモデュレーション業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Bioventus Inc.
    • Medtronic
    • Nevro Corporation
    • Neuronetics
    • MicroTransponder
    • NeuroPace Inc
    • Boston Scientific Corporation
    • MicroTransponder
    • LivaNova PLC
    • Abbott
    • NeuroSigma

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Neuromodulation Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Neuromodulation Market, by Technology 2019-2032 (USD Million)
  • TABLE Neuromodulation Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Neuromodulation Market, by Application 2019-2032 (USD Million)
  • TABLE Neuromodulation Market: BiomaterialSnapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Biomaterial
  • TABLE Global Neuromodulation Market, by Biomaterial2019-2032 (USD Million)
  • TABLE Neuromodulation Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Neuromodulation Market, by Region 2019-2032 (USD Million)
  • TABLE North America Neuromodulation Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Neuromodulation Market, by Technology, 2019-2032 (USD Million)
  • TABLE North America Neuromodulation Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Neuromodulation Market, by Biomaterial, 2019-2032 (USD Million)
  • TABLE Europe Neuromodulation Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Neuromodulation Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Neuromodulation Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Neuromodulation Market, by Biomaterial, 2019-2032 (USD Million)
  • TABLE Asia Pacific Neuromodulation Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Neuromodulation Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Neuromodulation Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Neuromodulation Market, by Biomaterial, 2019-2032 (USD Million)
  • TABLE Latin America Neuromodulation Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Neuromodulation Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Neuromodulation Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Neuromodulation Market, by Biomaterial, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Neuromodulation Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Neuromodulation Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Neuromodulation Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Neuromodulation Market, by Biomaterial, 2019-2032 (USD Million)
目次
Product Code: ANV2504

REPORT HIGHLIGHT

Neuromodulation Market size was valued at USD 5,987 Million in 2023, expanding at a CAGR of 11.5% from 2024 to 2032.

One technological advancement that directly affects nerves is neuromodulation. It is the change in nerve activity brought on by the direct application of medication or electricity to a specific location. The neuromodulation market uses state-of-the-art tools and therapies. They have an impact on every bodily system and are effective in treating almost all conditions, such as incontinence, tremors, migraines, and spinal cord injuries.

Neuromodulation Market- Market Dynamics

Increasing prevalence of neurological disorder to propel market demand

The neuromodulation market is expanding as neurological problems become more common. As we age, our bodies begin to lose their capacity to fight off infections and repair themselves, which leaves us more vulnerable to a host of chronic conditions like diabetes, Parkinson's disease, orthopedic difficulties, Alzheimer's disease, and gastrointestinal problems. There is an increasing number of people with neurological illnesses due to the global increase in the older population. Nonetheless, the percentage of the elderly population is much higher in nations like Greece, South Korea, Spain, Portugal, Japan, and Spain; by 2050, 40% of these nations' populations are predicted to be over 65. The number of people 65 years of age or older is expected to nearly treble globally by 2050. Therefore, the adoption of neuromodulation devices is projected to be driven by the notable increase in the ageing population, which is marked by a high prevalence of neurological illnesses. This will contribute to the expansion of the worldwide neuromodulation market throughout the forecast period.

Neuromodulation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.5% over the forecast period (2024-2032)

Based on technology, the Internal Neuromodulation segment is expected to grow at the highest CAGR during the forecast period

Based on application segmentation, the Parkinson's Disease segment is expected to lead the market over the projected period

Based on region, North America was the leading revenue generator in 2023

Neuromodulation Market- Segmentation Analysis:

The Global Neuromodulation Market is segmented based on Technology, Application, Biomaterial, and Region.

Based on the technology, the market is categorized into Internal Neuromodulation and External Neuromodulation. The Internal Neuromodulation segment is expected to grow at the highest CAGR during the forecast period. Patients with chronic neurological and pain diseases may find significant alleviation from their symptoms with the use of internal neuromodulation therapies, which give targeted and adjustable stimulation. The efficacy and application of these therapies are anticipated to improve with additional technological advancements, fueling further market expansion in the internal neuromodulation segment.

Based on the application, the industry is divided into Migraine, Chronic Pain, Failed Back Syndrome, Urinary And Fecal Incontinence, Parkinson's Disease, Epilepsy, Tremor, Depression and Others. The Parkinson's Disease segment is expected to lead the market over the projected period owing to the growing ageing population.

Neuromodulation Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The large pharmaceutical and biopharmaceutical industries, together with the presence of well-established market players and growing investments in the United States for the adoption of cutting-edge technologies, are anticipated to drive the market's expansion in the nation. According to updated data from the Parkinson's Foundation in 2022, for example, the yearly diagnosis rate of Parkinson's disease (PD) in the United States is anticipated to be about 90,000, a 50% rise from the previous projection of 60,000 diagnoses.

Neuromodulation Market- Competitive Landscape:

The key players operating in the market include Bioventus Inc., Medtronic, Nevro Corporation, Neuronetics, MicroTransponder, NeuroPace Inc., Boston Scientific Corporation, MicroTransponder, LivaNova PLC, Abbott and NeuroSigma. These players adopted several strategies to capture the maximum market share such as product launch, acquisition, expansion and others.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEUROMODULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Bioventus Inc.

Medtronic

Nevro Corporation

Neuronetics

MicroTransponder

NeuroPace Inc

Boston Scientific Corporation

MicroTransponder

LivaNova PLC

Abbott

NeuroSigma

GLOBAL NEUROMODULATION MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Internal Neuromodulation
  • External Neuromodulation

GLOBAL NEUROMODULATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Migraine
  • Chronic Pain
  • Failed Back Syndrome
  • Urinary And Fecal Incontinence
  • Parkinson Disease
  • Epilepsy
  • Tremor
  • Depression
  • Others

GLOBAL NEUROMODULATION MARKET, BY BIOMATERIAL- MARKET ANALYSIS, 2019 - 2032

  • Polymeric Biomaterials
  • Metallic Biomaterials
  • Ceramic Biomaterials

GLOBAL NEUROMODULATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Neuromodulation Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Neuromodulation Market Snippet by Technology
    • 2.1.2.Neuromodulation Market Snippet by Application
    • 2.1.3.Neuromodulation Market Snippet by Biomaterial
    • 2.1.4.Neuromodulation Market Snippet by Country
    • 2.1.5.Neuromodulation Market Snippet by Region
  • 2.2.Competitive Insights

3.Neuromodulation Key Market Trends

  • 3.1.Neuromodulation Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Neuromodulation Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Neuromodulation Market Opportunities
  • 3.4.Neuromodulation Market Future Trends

4.Neuromodulation Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Neuromodulation Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Neuromodulation Market Landscape

  • 6.1.Neuromodulation Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Neuromodulation Market - By Technology

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 7.1.2.Internal Neuromodulation
    • 7.1.3.External Neuromodulation

8.Neuromodulation Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Migraine
    • 8.1.3.Chronic Pain
    • 8.1.4.Failed Back Syndrome
    • 8.1.5.Urinary And Fecal Incontinence
    • 8.1.6.Parkinson Disease
    • 8.1.7.Epilepsy
    • 8.1.8.Tremor
    • 8.1.9.Depression
    • 8.1.10.Others

9.Neuromodulation Market - By Biomaterial

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Biomaterial, 2023 & 2032 (%)
    • 9.1.2.Polymeric Biomaterials
    • 9.1.3.Metallic Biomaterials
    • 9.1.4.Ceramic Biomaterials

10.Neuromodulation Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Neuromodulation Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Neuromodulation Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Neuromodulation Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Neuromodulation Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Neuromodulation Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Neuromodulation Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Bioventus Inc.
    • 11.2.2.Medtronic
    • 11.2.3.Nevro Corporation
    • 11.2.4.Neuronetics
    • 11.2.5.MicroTransponder
    • 11.2.6.NeuroPace Inc
    • 11.2.7.Boston Scientific Corporation
    • 11.2.8.MicroTransponder
    • 11.2.9.LivaNova PLC
    • 11.2.10.Abbott
    • 11.2.11.NeuroSigma

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Biomaterialology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us